Drugs / Bronchial basal cell
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT03092648 | Mar 2017 → Dec 2018 | chronic obstructive pulmonary disease | Nanfang Hospital, Southern Medical University | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bronchial basal cell | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03092648 ↗ |
| Modality | Cell therapy | “cultured cells will be transplanted autologously into the lesion” NCT03092648 ↗ |
| Route | Other | “into the lesion by fiberoptic bronchoscopy” NCT03092648 ↗ |